MedTrace Logo

Treatment as Prevention for Hepatitis C in Iceland

NCT02647879 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2020-09-25

No results posted yet for this study

Summary

The main aim of this study is to test in the Icelandic population the hypothesis that a nationwide treatment program which offers effective treatment to all known cases of Hepatitis C with the aim of halting HCV (Hepatitis C virus) transmission will lead to a reduction in incidence and disease burden associated with chronic HCV infection.

Conditions

  • Hepatitis C

Sponsors & Collaborators

  • National Center of Addiction Medicine (SAA)

    collaborator OTHER

  • Landspitali University Hospital

    lead OTHER

Principal Investigators

  • Sigurdur Olafsson, MD · Landspitali University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2021-12-31
Completion
2031-05-31

Countries

  • Iceland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02647879 on ClinicalTrials.gov